Literature DB >> 14569202

Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis.

Ericka P Simpson1, Albert A Yen, Stanley H Appel.   

Abstract

PURPOSE OF REVIEW: Amyotrophic lateral sclerosis, or Lou Gehrig disease, is a progressive neurodegenerative disease of adult onset characterized by a loss of motor neurons in the spinal cord and motor cortex. In the last several years, substantial progress has been made in defining the pathogenesis of motor neuron injury and relationships between disease mechanisms and the selective vulnerability of the motor neuron in both familial and sporadic forms of amyotrophic lateral sclerosis. RECENT
FINDINGS: Current theories have shifted from a neuron-centered pathology to a focus on the interaction between motor neurons and glia, and their respective contributions to pathways implicated in amyotrophic lateral sclerosis. Although multiple mechanisms clearly can contribute to the pathogenesis of motor neuron injury, recent advances suggest that oxidative stress may play a significant role in the amplification, and possibly the initiation, of disease.
SUMMARY: This article reviews the clinical aspects of amyotrophic lateral sclerosis and potential mechanisms of disease pathogenesis in the context of recent data supporting a major role for oxidative stress throughout the disease course. Evidence suggesting an important role for intercellular signaling is emphasized.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14569202     DOI: 10.1097/00002281-200311000-00008

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  33 in total

Review 1.  Autophagy as a cell-repair mechanism: activation of chaperone-mediated autophagy during oxidative stress.

Authors:  S Kaushik; A M Cuervo
Journal:  Mol Aspects Med       Date:  2006-09-15

Review 2.  Redox modifier genes and pathways in amyotrophic lateral sclerosis.

Authors:  Barrie J Carter; Pervin Anklesaria; Stephanie Choi; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

Review 3.  Potential Environmental Factors in Amyotrophic Lateral Sclerosis.

Authors:  Björn Oskarsson; D Kevin Horton; Hiroshi Mitsumoto
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

4.  Amyotrophic Lateral Sclerosis and Exposure to Diesel Exhaust in a Danish Cohort.

Authors:  Aisha S Dickerson; Johnni Hansen; Ole Gredal; Marc G Weisskopf
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

Review 5.  Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.

Authors:  Christi Kolarcik; Robert Bowser
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

6.  Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS.

Authors:  Barkha P Patel; Adeel Safdar; Sandeep Raha; Mark A Tarnopolsky; Mazen J Hamadeh
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

Review 7.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

8.  Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis.

Authors:  D Michal Freedman; Ralph W Kuncl; Stephanie J Weinstein; Nea Malila; Jarmo Virtamo; Demetrius Albanes
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-01-04       Impact factor: 4.092

9.  Fetal Alz-50 clone 1 interacts with the human orthologue of the Kelch-like Ech-associated protein.

Authors:  Gordon D Strachan; Kathleen L Morgan; Linda L Otis; John Caltagarone; Aryn Gittis; Robert Bowser; Kelly L Jordan-Sciutto
Journal:  Biochemistry       Date:  2004-09-28       Impact factor: 3.162

10.  Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease.

Authors:  Manoj Kumar Jaiswal; Wolf-Dieter Zech; Miriam Goos; Christine Leutbecher; Alberto Ferri; Annette Zippelius; Maria Teresa Carrì; Roland Nau; Bernhard U Keller
Journal:  BMC Neurosci       Date:  2009-06-22       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.